Literature DB >> 17548957

Decreased total antioxidant response and increased oxidative stress in Behcet's disease.

Ahmet Isik1, Suleyman Serdar Koca, Bilal Ustundag, Sahabettin Selek.   

Abstract

Behcet's disease (BD) is a chronic systemic inflammatory disease. Inflammatory reactions trigger the oxidative stress and oxidants decrease the level of antioxidants. In the present study, we aimed to determine serum oxidative/antioxidative status in patients with BD. Serum antioxidative status was evaluated by measuring total antioxidant capacity (TAC), paraoxonase 1, arylesterase, sulfhydryl groups and ceruloplasmin in patients with BD and in healthy controls. Serum oxidative status was evaluated by measuring total peroxide (TP), lipid hydroperoxides and oxidative stress index (OSI). OSI was calculated by percent ratio of TP to TAC. Serum levels of TAC, sulfhydryl groups and activities of paraoxonase 1, arylesterase, and ceruloplasmin were significantly lower in patients than in controls (p < 0.001 for all). In contrast, TP, lipid hydroperoxides and OSI values were significantly higher in patients than in controls (p < 0.001 for all). Further, the level of TAC was negatively correlated with the levels of TP, lipid hydroperoxides and OSI both in the BD (r = -0.578, p < 0.01; r = -0.559, p < 0.01 and r = -0.552, p < 0.01, respectively) and the control groups (r = -0.469, p < 0.05; r = -0.351, p < 0.05 and r = -0.391, p < 0.05, respectively). These results indicate that the oxidant parameters increased and antioxidant parameters decreased in patients with BD; therefore, these patients might have been exposed to oxidative stress. We suggest that impaired oxidant/antioxidant balance should be taken into consideration in the follow-up of patients with BD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548957     DOI: 10.1620/tjem.212.133

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  15 in total

1.  Assessment of genotoxicity associated with Behcet's disease using sister-chromatid exchange assay: vitamin E versus mitomycin C.

Authors:  Omar F Khabour; Khaldon Alawneh; Etizaz Al-Kofahi; Fahmee Mesmar
Journal:  Cytotechnology       Date:  2014-05-23       Impact factor: 2.058

2.  Protective effect of melatonin on infrarenal aortic occlusion: this effect is related to anti-inflammatory effect and antioxidant effect.

Authors:  Ahmet Ahsen; Yucel Gonul; Abdurrahman Genc; Memnune Sena Ulu; Murat Yagmurca; Cevdet Ugur Kocogullari; Sefa Celik; Seref Yuksel
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  Psoroptes cuniculi induced oxidative imbalance in rabbits and its alleviation by using vitamins A, D3, E, and H as adjunctive remedial.

Authors:  Shanker Kumar Singh; Umesh Dimri; Mahesh Chandra Sharma; Devendra Swarup; Mritunjay Kumar; Ramesh Tiwary
Journal:  Trop Anim Health Prod       Date:  2011-06-04       Impact factor: 1.559

4.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

5.  Visfatin levels and intima-media thicknesses in rheumatic diseases.

Authors:  Metin Ozgen; Suleyman Serdar Koca; Kader Aksoy; Necati Dagli; Bilal Ustundag; Ahmet Isik
Journal:  Clin Rheumatol       Date:  2010-12-17       Impact factor: 2.980

6.  Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.

Authors:  Yavuz Yesilova; Enver Turan; Derya Ucmak; Sahabettin Selek; İbrahim Halil Yavuz; Osman Tanrıkulu
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

7.  Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Authors:  Fazile Hatipoglu Erdem; Saliha Karatay; Kadir Yildirim; Ahmet Kiziltunc
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

8.  Serum levels of natriuretic peptides in patients with Behcet's disease.

Authors:  Ramazan Yağci; Yüksel Totan; Ekin Ozlük; Hüseyin Ozyurt; Gülfer Akbay; Meral Ekşioğlu
Journal:  Clin Rheumatol       Date:  2008-04-15       Impact factor: 2.980

9.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

10.  Serum adropin level and ENHO gene expression in systemic sclerosis.

Authors:  Servet Yolbas; Murat Kara; Musa Yilmaz; Suleyman Aydin; Suleyman Serdar Koca
Journal:  Clin Rheumatol       Date:  2016-04-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.